Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

The document suggests that drugs for prostate issues might cause lasting sexual, mental, and physical health problems due to blood vessel damage in the penis.

Finasteride does not negatively affect male reproductive function.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.